🔗 Share this article

Texas Attorney General Paxton is taking legal action against the manufacturers of acetaminophen, asserting the companies withheld alleged dangers that the pain reliever posed to children's neurological development.

This legal action comes thirty days after President Donald Trump publicized an unverified association between taking acetaminophen - referred to as acetaminophen - during pregnancy and autism in offspring.

Paxton is filing suit against Johnson & Johnson, which previously sold the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he stated they "misled consumers by profiting off of suffering and pushing pills ignoring the dangers."

The company states there is insufficient reliable data tying acetaminophen to autism.

"These manufacturers lied for decades, knowingly endangering countless individuals to increase profits," Paxton, from the Republican party, declared.

The manufacturer commented that it was "seriously troubled by the spread of false claims on the security of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its website, the company also mentioned it had "consistently assessed the relevant science and there is lacking reliable evidence that indicates a verified association between taking paracetamol and autism."

Associations acting on behalf of medical professionals and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the key substance in acetaminophen - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can pose serious health risks if left untreated.

"In over twenty years of studies on the consumption of acetaminophen in pregnancy, no reliable research has definitively established that the usage of acetaminophen in any stage of gestation leads to neurodevelopmental disorders in children," the association said.

The court filing mentions recent announcements from the previous government in claiming the drug is potentially dangerous.

Recently, Trump caused concern from medical authorities when he told women during pregnancy to "struggle intensely" not to take Tylenol when ill.

The FDA then released a statement that medical professionals should consider limiting the use of acetaminophen, while also stating that "a causal relationship" between the drug and autism in minors has not been established.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had pledged in spring to initiate "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a limited time.

But experts warned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a form of enduring cognitive variation and impairment that influences how individuals experience and relate to the world, and is diagnosed using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is campaigning for US Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the research" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the firms "destroy any promotional materials" that claims Tylenol is secure for women during pregnancy.

This legal action parallels the complaints of a assembly of guardians of young ones with autism and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in two years ago.

A federal judge threw out the lawsuit, stating studies from the family's specialists was inconclusive.